Tumor recurrence remains to be an obstacle after liver organ medical operation especially in living donor liver organ transplantation (LDLT) for sufferers with hepatocellular carcinoma (HCC). in small-for-size group was considerably greater than that entirely graft group at time 1 (251 ± 53 pg/ml 119 ± 10 pg/ml = 0.013) and time 7 (251 ±… Continue reading Tumor recurrence remains to be an obstacle after liver organ medical